{"id":405422,"date":"2025-11-26T07:11:16","date_gmt":"2025-11-26T07:11:16","guid":{"rendered":"https:\/\/www.europesays.com\/us\/405422\/"},"modified":"2025-11-26T07:11:16","modified_gmt":"2025-11-26T07:11:16","slug":"u-s-negotiates-lower-prices-for-ozempic-and-14-other-drugs","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/405422\/","title":{"rendered":"U.S. Negotiates Lower Prices for Ozempic and 14 Other Drugs"},"content":{"rendered":"<p data-type=\"paragraph\" data=\"[object Object]\" class=\"css-1akm6h5-Paragraph e1e4oisd0\">The U.S. government negotiated lower prices in the federal Medicare program for 15 high-selling medicines <a data-type=\"link\" href=\"https:\/\/www.wsj.com\/health\/pharma\/ozempic-glp1-weight-loss-mass-market-f70f8484?mod=article_inline\" target=\"_blank\" rel=\"noreferrer nofollow noopener\" class=\"ekxajjj0 css-i0lbhy-OverridedLink\">including Ozempic<\/a>, widening an effort to <a data-type=\"link\" href=\"https:\/\/www.wsj.com\/health\/pharma\/expensive-drugs-from-pfizer-other-companies-targeted-for-first-u-s-price-negotiations-9942b20b?mod=article_inline\" target=\"_blank\" class=\"ekxajjj0 css-i0lbhy-OverridedLink\" rel=\"nofollow noopener\">rein in drug costs<\/a>.<\/p>\n<p data-type=\"paragraph\" data=\"[object Object]\" class=\"css-1akm6h5-Paragraph e1e4oisd0\">The new prices, which will take effect in 2027, shave 38% to 85% off the list prices for drugs for diseases including asthma, cancer and diabetes. The reductions are estimated to save Medicare, the <a data-type=\"link\" href=\"https:\/\/www.wsj.com\/health\/pharma\/ozempic-glp1-weight-loss-mass-market-f70f8484?mod=article_inline\" target=\"_blank\" rel=\"noreferrer nofollow noopener\" class=\"ekxajjj0 css-i0lbhy-OverridedLink\">health-insurance program<\/a> for the elderly, $12 billion.<\/p>\n<p class=\"css-16aepit e1jdulti0\">Copyright \u00a92025 Dow Jones &amp; Company, Inc. All Rights Reserved. 87990cbe856818d5eddac44c7b1cdeb8<\/p>\n","protected":false},"excerpt":{"rendered":"The U.S. government negotiated lower prices in the federal Medicare program for 15 high-selling medicines including Ozempic, widening&hellip;\n","protected":false},"author":3,"featured_media":405423,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[34],"tags":[235,19451,190830,191371,191378,190835,12024,60,57,191365,190844,190832,190831,191369,126181,191373,191379,210,191367,1142,191368,191370,190843,7337,10273,27531,191384,191383,191386,191385,191381,191382,3221,135,191372,88900,24788,1060,29591,191376,191366,587,9412,191377,191375,30898,191380,152,3234,190263,80,190834,6769,5660,114399,191374,67,132,68,190235],"class_list":["post-405422","post","type-post","status-publish","format-standard","has-post-thumbnail","category-medication","tag-cancer","tag-corporate","tag-corporate-industrial-news","tag-diabetes-drugs","tag-dknovo-b","tag-domestic-politics","tag-economic-news","tag-financial-services","tag-general-news","tag-gfx-contrib","tag-government-budget","tag-government-budget-taxation","tag-government-finance","tag-government-sponsored-health-insurance","tag-gsk","tag-gsk-ln","tag-gsks","tag-health","tag-health-medical-insurance","tag-healthcare","tag-healthcare-life-sciences","tag-hormone-products","tag-industrial-news","tag-insurance","tag-international-relations","tag-life-sciences","tag-linki1-wp-wsj-0003121789","tag-linki2-wp-wsj-0003121789","tag-linki3-wp-wsj-0003121789","tag-linki4-wp-wsj-0003121789","tag-linki5-wp-wsj-0003121789","tag-linki6-wp-wsj-0003121789","tag-marketing","tag-markets","tag-markets-marketing","tag-medical-conditions","tag-medical-insurance","tag-medication","tag-merck","tag-mrk","tag-non-life-insurance","tag-north-america","tag-novo-nordisk","tag-novo-b-ko","tag-pfe","tag-pfizer","tag-pfizers","tag-pharmaceuticals","tag-political","tag-political-general-news","tag-politics","tag-politics-international-relations","tag-prices","tag-synd","tag-taxation","tag-ukgsk","tag-united-states","tag-unitedstates","tag-us","tag-wsj-pro-wsj-com"],"share_on_mastodon":{"url":"","error":"Validation failed: Text character limit of 500 exceeded"},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/405422","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=405422"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/405422\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/405423"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=405422"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=405422"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=405422"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}